Sullivan Keith J 4
4 · Neuronetics, Inc. · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Neuronetics (STIM) CEO Keith Sullivan Sells 8,452 Shares
What Happened
- Keith J. Sullivan, President, CEO and Director of Neuronetics, sold 8,452 shares on Feb 26, 2026. The reported weighted-average price was $1.35 per share, for total proceeds of approximately $11,410. This was a sale (routine cashing of vested equity), not a purchase.
Key Details
- Transaction date: 2026-02-26; Form 4 filed 2026-02-27 (appears timely).
- Price: weighted average $1.35; individual sale prices ranged from $1.38 to $1.31.
- Total shares sold: 8,452; total proceeds ≈ $11,410.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Footnote F1: Sales were non-discretionary to satisfy the reporting person’s tax withholding obligation upon vesting of a portion of a restricted stock unit (RSU) award.
- Footnote F2: The $1.35 figure is a weighted average; the filer will provide per‑trade details on request to the SEC staff, the issuer, or any stockholder.
Context
- This sale was to cover tax withholding on vested RSUs, a routine administrative transaction (often labeled “sell-to-cover”) and not necessarily an indicator of the CEO’s view on the company’s prospects. The small dollar amount ($~11.4k) further suggests a routine withholding sale rather than a substantive portfolio move.
Insider Transaction Report
Form 4
Sullivan Keith J
DirectorPresident and CEO
Transactions
- Sale
Common Stock
[F1][F2]2026-02-26$1.35/sh−8,452$11,410→ 1,524,713 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.38 to $1.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Patrick Devine, as Attorney-in-Fact|2026-02-27